Literature DB >> 27561191

Performance of the GRACE Risk Score 2.0 Simplified Algorithm for Predicting 1-Year Death After Hospitalization for an Acute Coronary Syndrome in a Contemporary Multiracial Cohort.

Wei Huang1, Gordon FitzGerald2, Robert J Goldberg3, Joel Gore4, Richard H McManus3, Hamza Awad5, Molly E Waring3, Jeroan Allison3, Jane S Saczynski6, Catarina I Kiefe3, Keith A A Fox7, Frederick A Anderson2, David D McManus4.   

Abstract

The GRACE Risk Score is a well-validated tool for estimating short- and long-term risk in acute coronary syndrome (ACS). GRACE Risk Score 2.0 substitutes several variables that may be unavailable to clinicians and, thus, limit use of the GRACE Risk Score. GRACE Risk Score 2.0 performed well in the original GRACE cohort. We sought to validate its performance in a contemporary multiracial ACS cohort, in particular in black patients with ACS. We evaluated the performance of the GRACE Risk Score 2.0 simplified algorithm for predicting 1-year mortality in 2,131 participants in Transitions, Risks, and Actions in Coronary Events Center for Outcomes Research and Education (TRACE-CORE), a multiracial cohort of patients discharged alive after an ACS in 2011 to 2013 from 6 hospitals in Massachusetts and Georgia. The median age of study participants was 61 years, 67% were men, and 16% were black. Half (51%) of the patients experienced a non-ST-segment elevation myocardial infarction (NSTEMI) and 18% STEMI. Eighty patients (3.8%) died within 12 months of discharge. The GRACE Risk Score 2.0 simplified algorithm demonstrated excellent model discrimination for predicting 1-year mortality after hospital discharge in the TRACE-CORE cohort (c-index = 0.77). The c-index was 0.94 in patients with STEMI, 0.78 in those with NSTEMI, and 0.87 in black patients with ACS. In conclusion, the GRACE Risk Score 2.0 simplified algorithm for predicting 1-year mortality exhibited excellent model discrimination across the spectrum of ACS types and racial/ethnic subgroups and, thus, may be a helpful tool to guide routine clinical care for patients with ACS.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27561191      PMCID: PMC5050116          DOI: 10.1016/j.amjcard.2016.07.029

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  18 in total

1.  Risk stratification and therapeutic decision making in acute coronary syndromes.

Authors:  E M Ohman; C B Granger; R A Harrington; K L Lee
Journal:  JAMA       Date:  2000-08-16       Impact factor: 56.272

2.  ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.

Authors:  Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Jonathan L Halperin; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2007-08-06       Impact factor: 29.690

3.  A 35-Year Perspective (1975 to 2009) into the Long-Term Prognosis and Hospital Management of Patients Discharged from the Hospital After a First Acute Myocardial Infarction.

Authors:  Han-Yang Chen; Joel M Gore; Kate L Lapane; Jorge Yarzebski; Sharina D Person; Jerry H Gurwitz; Catarina I Kiefe; Robert J Goldberg
Journal:  Am J Cardiol       Date:  2015-04-06       Impact factor: 2.778

4.  Characteristics of contemporary patients discharged from the hospital after an acute coronary syndrome.

Authors:  Robert J Goldberg; Jane S Saczynski; David D McManus; Molly E Waring; Richard McManus; Jeroan Allison; David C Parish; Darleen Lessard; Sharina Person; Joel M Gore; Catarina I Kiefe
Journal:  Am J Med       Date:  2015-05-23       Impact factor: 4.965

5.  Evaluating the yield of medical tests.

Authors:  F E Harrell; R M Califf; D B Pryor; K L Lee; R A Rosati
Journal:  JAMA       Date:  1982-05-14       Impact factor: 56.272

6.  Transitions, Risks, and Actions in Coronary Events--Center for Outcomes Research and Education (TRACE-CORE): design and rationale.

Authors:  Molly E Waring; Richard H McManus; Jane S Saczynski; Milena D Anatchkova; David D McManus; Randolph S Devereaux; Robert J Goldberg; Jeroan J Allison; Catarina I Kiefe
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-09-01

7.  Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-up.

Authors:  Sami M A Alnasser; Wei Huang; Joel M Gore; Ph Gabriel Steg; Kim A Eagle; Frederick A Anderson; Keith A A Fox; Enrique Gurfinkel; David Brieger; Werner Klein; Frans van de Werf; Álvaro Avezum; Gilles Montalescot; Dietrich C Gulba; Andrzej Budaj; Jose Lopez-Sendon; Christopher B Granger; Brian M Kennelly; Robert J Goldberg; Emily Fleming; Shaun G Goodman
Journal:  Am J Med       Date:  2014-12-29       Impact factor: 4.965

8.  The impact of race on the acute management of chest pain.

Authors:  Arvind Venkat; James Hoekstra; Christopher Lindsell; Dawn Prall; Judd E Hollander; Charles V Pollack; Deborah Diercks; J Douglas Kirk; Brian Tiffany; Frank Peacock; Alan B Storrow; W Brian Gibler
Journal:  Acad Emerg Med       Date:  2003-11       Impact factor: 3.451

9.  Sensitive troponin I assay in early diagnosis of acute myocardial infarction.

Authors:  Till Keller; Tanja Zeller; Dirk Peetz; Stergios Tzikas; Alexander Roth; Ewa Czyz; Christoph Bickel; Stephan Baldus; Ascan Warnholtz; Meike Fröhlich; Christoph R Sinning; Medea S Eleftheriadis; Philipp S Wild; Renate B Schnabel; Edith Lubos; Nicole Jachmann; Sabine Genth-Zotz; Felix Post; Viviane Nicaud; Laurence Tiret; Karl J Lackner; Thomas F Münzel; Stefan Blankenberg
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

10.  Implicit bias among physicians and its prediction of thrombolysis decisions for black and white patients.

Authors:  Alexander R Green; Dana R Carney; Daniel J Pallin; Long H Ngo; Kristal L Raymond; Lisa I Iezzoni; Mahzarin R Banaji
Journal:  J Gen Intern Med       Date:  2007-06-27       Impact factor: 5.128

View more
  14 in total

1.  Comparison of RANKL expression, inflammatory markers, and cardiovascular risk in patients with acute coronary syndrome with and without rheumatoid arthritis.

Authors:  Velichka Popova; Zaprin Vazhev; Mariela Geneva-Popova; Anastas Batalov
Journal:  Rheumatol Int       Date:  2019-07-11       Impact factor: 2.631

2.  Association of Prolonged Emergency Department Length of Stay with Adverse Events in Patients with Non-ST-Elevation Acute Coronary Syndrome.

Authors:  Thanya Limapichat; Sakarin Kaewyingyong
Journal:  Open Access Emerg Med       Date:  2022-03-10

3.  Diagnostic Model of In-Hospital Mortality in Patients with Acute ST-Segment Elevation Myocardial Infarction Used Artificial Intelligence Methods.

Authors:  Yong Li
Journal:  Cardiol Res Pract       Date:  2022-05-25       Impact factor: 1.990

Review 4.  Machine learning for predicting cardiac events: what does the future hold?

Authors:  Brijesh Patel; Partho Sengupta
Journal:  Expert Rev Cardiovasc Ther       Date:  2020-02-23

Review 5.  Importance of Endogenous Fibrinolysis in Platelet Thrombus Formation.

Authors:  Ying X Gue; Diana A Gorog
Journal:  Int J Mol Sci       Date:  2017-08-25       Impact factor: 5.923

6.  Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary Syndromes.

Authors:  Nicolas Vuilleumier; Sabrina Pagano; Christophe Combescure; Baris Gencer; Julien Virzi; Lorenz Räber; David Carballo; Sebastian Carballo; David Nanchen; Nicolas Rodondi; Stephan Windecker; Stanley L Hazen; Zeneng Wang; Xinmin S Li; Arnold von Eckardstein; Christian M Matter; Thomas F Lüscher; Roland Klingenberg; Francois Mach
Journal:  J Clin Med       Date:  2019-07-09       Impact factor: 4.241

Review 7.  Defining and managing patients with non-ST-elevation myocardial infarction: Sorting through type 1 vs other types.

Authors:  Marc Cohen; Gautam Visveswaran
Journal:  Clin Cardiol       Date:  2020-01-10       Impact factor: 2.882

8.  Long-Term Clinical Outcomes for Non-ST Elevation Acute Coronary Syndrome Patients with High-Risk Angiographic Findings Undergoing Percutaneous Coronary Intervention.

Authors:  Sida Jia; Ce Zhang; Yue Liu; Deshan Yuan; Xueyan Zhao; Runlin Gao; Yuejin Yang; Bo Xu; Zhan Gao; Jinqing Yuan
Journal:  J Interv Cardiol       Date:  2020-05-07       Impact factor: 2.279

9.  Evaluation of the impact of the GRACE risk score on the management and outcome of patients hospitalised with non-ST elevation acute coronary syndrome in the UK: protocol of the UKGRIS cluster-randomised registry-based trial.

Authors:  Colin C Everett; Keith Aa Fox; Catherine Reynolds; Catherine Fernandez; Linda Sharples; Deborah D Stocken; Kathryn Carruthers; Harry Hemingway; Andrew T Yan; Shaun G Goodman; David Brieger; Derek P Chew; Chris P Gale
Journal:  BMJ Open       Date:  2019-09-05       Impact factor: 2.692

10.  Design and rationale for the "Me & My Heart" (eMocial) study: A randomized evaluation of a new smartphone-based support tool to increase therapy adherence of patients with acute coronary syndrome.

Authors:  Florian Krackhardt; Lars S Maier; Karl-Friedrich Appel; Till Köhler; Alexander Ghanem; Carsten Tschoepe; Jürgen Vom Dahl; Ralf Degenhardt; Anna Niklasson; Matti Ahlqvist; Matthias W Waliszewski; Magnus Jörnten-Karlsson
Journal:  Clin Cardiol       Date:  2019-09-06       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.